Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Journal Club
  • Published:

NRI AT 20: INFLAMMATION

Resolving inflammation

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

Original articles

  • Gilroy, D. W. et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5, 698–701 (1999)

    Article  CAS  Google Scholar 

  • Wilson, E. B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202–207 (2013)

    Article  CAS  Google Scholar 

  • Teijaro, J. R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207–211 (2013)

    Article  CAS  Google Scholar 

Related articles

  • Chiang, N. & Serhan, C. N. Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem. 64, 443–462 (2020)

    Article  CAS  Google Scholar 

  • Boada-Romero, E. et al. The clearance of dead cells by efferocytosis. Nat. Rev. Mol. Cell Biol. 21, 398–414 (2020)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Derek W. Gilroy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gilroy, D.W. Resolving inflammation. Nat Rev Immunol 21, 620–621 (2021). https://doi.org/10.1038/s41577-021-00597-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41577-021-00597-w

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research